Tidal energy turbines are a new renewable energy technology that will be demonstrated at the FORCE test site in the Bay of Fundy. The potential negative effects of these turbines on fish are of high concern to industry, regulators, fishers, and other stakeholders. This research will use sonars attached to sensor platforms deployed on the […]

Le camerisier, ou chèvrefeuille comestible (Lonicera caerulea), fait partie des cultures fruitières en émergence au Québec. Toutefois, bien que le camerisier soit cultivé au Québec depuis près d’une décennie, très peu d’information agronomique sur cette culture a été scientifiquement publiée jusqu’à maintenant. Dans l’optique de préciser la régie de la fertilisation pour la camerise, les […]

Sub-clinical disease results in reduced growth and less efficient use of nutrients, resulting in substantial impact on profitability of pork producers. With the elimination of in-feed antibiotics for growth promotion it is increasingly important to understand the interaction between nutrition and health and nutrient requirements during disease challenge events. Feeding high-fibre feedstuffs reduces the efficiency […]

Le diabète de type II est une maladie complexe qui se caractérise par une hausse de glucose dans le sang causée par un débalancement de certaines protéines. Il est possible de mesurer simultanément la concentration de ces protéines par des approches, dites « multiplex ». Par contre, la présence de réactions croisées dans ces essais […]

Prostate cancer will affect 1 in 7 Canadian males. While the number of therapeutic options is increasing, matching each patient to the right therapy remains as the challenge for a personalized approach to patient management. Currently, most of the attention has focused on identifying biological tags that can predict patients response. We have developed an […]

Prostate cancer is the disease of the old, effecting 1 in 7 Canadians with a death burden of 1 in 28. The management of the disease becomes extremely difficult with the development of the nonresponsive and aggressive form of the cancer. Thus, the clinicians are rendered helpless and hence there is an urgent need for […]

In vitro embryo production and embryo transfer (IVP/ET) is a technique that has been developed in cattle for genetic selection to enable rapid improvement in commercially important traits. Technological advances have resulted in a significant increase in the commercial use of IVP/ET in recent years, and have made this one of the fastest growing sectors […]

In vitro embryo production and embryo transfer (IVP/ET) is a technique that has been developed in cattle for genetic selection to enable rapid improvement in commercially important traits. Technological advances have resulted in a significant increase in the commercial use of IVP/ET in recent years, and have made this one of the fastest growing sectors […]

The planned research program aims to address an existing gap: the lack of commercial availability of reference materials for food allergens to be used in the context of analytical method development, validation and performance testing. In particular, naturally incurred samples representing food matrices where priority allergens are likely to occur, in a controlled and calibrated […]

The planned research program aims to address an existing gap: the lack of commercial availability of reference materials for food allergens to be used in the context of analytical method development, validation and performance testing. In particular, naturally incurred samples representing food matrices where priority allergens are likely to occur, in a controlled and calibrated […]

The planned research aims to validate food allergen testing tools from r-Biopharm Canada, and their incorporation in novel quality-management systems used in food production. The first part of the project consists in developing validation criteria for allergen methods under the auspices of the Association of Official Analytical Communities (AOAC) and apply these new requirements for […]

Au Canada, le cancer épithélial de l’ovaire (CEO) est à l’origine de 1500 décès par an. Etant donné qu’aucune amélioration de la survie des patientes n’a été observée durant les dernières décennies, il devient impératif de développer de nouvelles stratégies thérapeutiques de ce cancer. Le CEO est caractérisé par une hétérogénéité accrue qui s’installe dès […]